Role of MMP-9 in the breakdown of barrier integrity of the corneal endothelium in response to TNF-α

Experimental Eye Research

Volumn 122, Issue , 2014, Pages 77-85

  Rajashekhar, Gangaraju ^a   Shivanna, Mahesh ^b   Kompella, Uday B ^c   Wang, Yueren ^d   Srinivas, Sangly P ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Corneal endothelium; Matrix metalloproteinases; P38 MAP kinase; Tight junctions; TNF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOHEXIMIDE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GELATIN; GELATINASE A; GELATINASE B; ILOMASTAT; MESSENGER RNA; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DRUG EFFECT; ELECTRIC RESISTANCE; ENZYME ACTIVITY; ENZYME INHIBITION; EXPOSURE; IMMUNOLOCALIZATION; NONHUMAN; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; ZYMOGRAPHY;

CORNEAL ENDOTHELIUM; MATRIX METALLOPROTEINASES; P38 MAP KINASE; TIGHT JUNCTIONS; TNF-Α;

ANIMALS; CATTLE; CELLS, CULTURED; CYCLOHEXIMIDE; DEXTRANS; ELECTRIC IMPEDANCE; ENDOTHELIUM, CORNEAL; FLUORESCEIN-5-ISOTHIOCYANATE; GENE EXPRESSION REGULATION; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; REAL-TIME POLYMERASE CHAIN REACTION; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84904428205     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.03.004     Document Type: Article

References (72)

1. Bhattacharjee A.K., Kondoh T., Ikeda M., Kohmura E. MMP-9 and EBA immunoreactivity after papaverine mediated opening of the blood-brain barrier. Neuroreport 2002, 13(17):2217-2221.
2. Bonoiu A., Mahajan S.D., Ye L., Kumar R., Ding H., Yong K.T., Roy I., Aalinkeel R., Nair B., Reynolds J.L., Sykes D.E., Imperiale M.A., Bergey E.J., Schwartz S.A., Prasad P.N. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res. 2009, 1282:142-155.
3. Borkenstein A., Faschinger C., Maier R., Weger M., Theisl A., Demel U., Graninger W., Irene H., Mossbock G. Measurement of tumor necrosis factor-alpha, interleukin-6, Fas ligand, interleukin-1alpha, and interleukin-1beta in the aqueous humor of patients with open angle glaucoma using multiplex bead analysis. Mol. Vis. 2013, 19:2306-2311.
4. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J.Immunol. 2003, 171(11):6164-6172.
5. Capaldo C.T., Nusrat A. Cytokine regulation of tight junctions. Biochim. Biophys. Acta 2009, 1788(4):864-871.
6. Cuenda A., Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773(8):1358-1375.
7. Denker B.M., Nigam S.K. Molecular structure and assembly of the tight junction. Am. J. Physiol. 1998, 274(1 Pt 2):F1-F9.
8. Duran-Vilaregut J., del Valle J., Manich G., Camins A., Pallas M., Vilaplana J., Pelegri C. Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease. Neuropathol. Appl. Neurobiol. 2011, 37(5):525-537.
9. Edelhauser H.F. The balance between corneal transparency and edema: the Proctor Lecture. Investig. Ophthalmol. Vis. Sci. 2006, 47(5):1754-1767.
10. Ennis H.L., Lubin M. Cycloheximide: aspects of inhibition of protein synthesis in mammalian cells. Science 1964, 146(3650):1474-1476.
11. Feldman L.J., Mazighi M., Scheuble A., Deux J.F., De Benedetti E., Badier-Commander C., Brambilla E., Henin D., Steg P.G., Jacob M.P. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 2001, 103(25):3117-3122.
12. Fini M.E., Cook J.R., Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch. Dermatol. Res. 1998, 290(Suppl.):S12-S23.
13. Fischbarg J., Diecke F.P., Iserovich P., Rubashkin A. The role of the tight junction in paracellular fluid transport across corneal endothelium. Electro-osmosis as a driving force. J.Membr. Biol. 2006, 210(2):117-130.
14. George A.J., Larkin D.F. Corneal transplantation: the forgotten graft. Am. J. Transpl. 2004, 4(5):678-685.
15. Goldberg G.I., Marmer B.L., Grant G.A., Eisen A.Z., Wilhelm S., He C.S. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(21):8207-8211.
16. Goldblum S.E., Ding X., Campbell-Washington J. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am. J. Physiol. 1993, 264(4 Pt 1):C894-C905.
17. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 1997, 74(2):111-122.
18. Guay J., Lambert H., Gingras-Breton G., Lavoie J.N., Huot J., Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J.Cell Sci. 1997, 110(Pt 3):357-368.
19. Hu J., Zhang Z., Xie H., Chen L., Zhou Y., Chen W., Liu Z. Serine protease inhibitor A3K protects rabbit corneal endothelium from barrier function disruption induced by TNF-alpha. Investig. Ophthalmol. Vis. Sci. 2013, 54(8):5400-5407.
20. Huet E., Vallee B., Delbe J., Mourah S., Pruliere-Escabasse V., Tremouilleres M., Kadomatsu K., Doan S., Baudouin C., Menashi S., Gabison E.E. EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. Am. J. Pathol. 2011, 179(3):1278-1286.
21. Huveneers S., Danen E.H. Adhesion signaling - crosstalk between integrins, Src and Rho. J.Cell Sci. 2009, 122(Pt 8):1059-1069.
22. Jalimarada S.S., Shivanna M., Kini V., Mehta D., Srinivas S.P. Microtubule disassembly breaks down the barrier integrity of corneal endothelium. Exp. Eye Res. 2009, 89(3):333-343.
23. Khokha R., Murthy A., Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat. Rev. Immunol. 2013, 13(9):649-665.
24. Krizanac-Bengez L., Hossain M., Fazio V., Mayberg M., Janigro D. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic invitro blood-brain barrier model: role of pro-inflammatory cytokines. Am. J. Physiol. Cell Physiol. 2006, 291(4):C740-C749.
25. Kuo J.C. Mechanotransduction at focal adhesions: integrating cytoskeletal mechanics in migrating cells. J.Cell. Mol. Med. 2013, 17(6):704-712.
26. Lambert E., Dasse E., Haye B., Petitfrere E. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 2004, 49(3):187-198.
27. Lee S.J., Park S.S., Cho Y.H., Park K., Kim E.J., Jung K.H., Kim S.K., Kim W.J., Moon S.K. Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways. Oncol. Rep. 2008, 19(4):1007-1013.
28. Leppert D., Leib S.L., Grygar C., Miller K.M., Schaad U.B., Hollander G.A. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin. Infect. Dis. 2000, 31(1):80-84.
29. Lohmann C., Krischke M., Wegener J., Galla H.J. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res. 2004, 995(2):184-196.
30. Ma T.Y., Boivin M.A., Ye D., Pedram A., Said H.M. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288(3):G422-G430.
31. Mackay A.R., Ballin M., Pelina M.D., Farina A.R., Nason A.M., Hartzler J.L., Thorgeirsson U.P. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 1992, 12(3-4):168-184.
32. Maier P., Heizmann U., Bohringer D., Kern Y., Reinhard T. Distinct cytokine pattern in aqueous humor during immune reactions following penetrating keratoplasty. Mol. Vis. 2010, 16:53-60.
33. Maier P., Heizmann U., Bohringer D., Kern Y., Reinhard T. Predicting the risk for corneal graft rejection by aqueous humor analysis. Mol. Vis. 2011, 17:1016-1023.
34. Manicone A.M., McGuire J.K. Matrix metalloproteinases as modulators of inflammation. Semin. Cell Dev. Biol. 2008, 19(1):34-41.
35. Matsubara K., Kakunaga M. The genome efforts in Japan as of 1991. Genomics 1992, 12(3):618-620.
36. Matsumoto Y., Park I.K., Kohyama K. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy. J.Immunol. 2009, 183(7):4773-4781.
37. McKenzie J.A., Ridley A.J. Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J.Cell. Physiol. 2007, 213(1):221-228.
38. Nagase H., Woessner J.F. Matrix metalloproteinases. J.Biol. Chem. 1999, 274(31):21491-21494.
39. Nee L.E., McMorrow T., Campbell E., Slattery C., Ryan M.P. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int. 2004, 66(4):1376-1386.
40. Niederkorn J.Y. Mechanisms of corneal graft rejection: the sixth annual Thygeson lecture, presented at the Ocular Microbiology and Immunology Group meeting, October 21, 2000. Cornea 2001, 20(7):675-679.
41. Niederkorn J.Y. Immune mechanisms of corneal allograft rejection. Curr. Eye Res. 2007, 32(12):1005-1016.
42. Noske W., Fromm M., Levarlet B., Kreusel K.M., Hirsch M. Tight junctions of the human corneal endothelium: morphological and electrophysiological features. Ger. J. Ophthalmol. 1994, 3(4-5):253-257.
43. Nusrat A., Turner J.R., Madara J.L. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279(5):G851-G857.
44. Nwariaku F.E., Chang J., Zhu X., Liu Z., Duffy S.L., Halaihel N.H., Terada L., Turnage R.H. The role of p38 map kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability. Shock 2002, 18(1):82-85.
45. Peifer C., Wagner G., Laufer S. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Curr. Top. Med. Chem. 2006, 6(2):113-149.
46. Petrache I., Birukova A., Ramirez S.I., Garcia J.G., Verin A.D. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am. J. Respir. Cell Mol. Biol. 2003, 28(5):574-581.
47. Rae M.T., Price D., Harlow C.R., Critchley H.O., Hillier S.G. Glucocorticoid receptor-mediated regulation of MMP9 gene expression in human ovarian surface epithelial cells. Fertil. Steril. 2009, 92(2):703-708.
48. Rajashekhar G., Kamocka M., Marin A., Suckow M.A., Wolter W.R., Badve S., Sanjeevaiah A.R., Pumiglia K., Rosen E., Clauss M. Pro-inflammatory angiogenesis is mediated by p38 MAP kinase. J.Cell. Physiol. 2011, 226(3):800-808.
49. Rajashekhar G., Loganath A., Roy A.C., Chong S.S., Wong Y.C. Extracellular matrix-dependent regulation of angiogenin expression in human placenta. J.Cell. Biochem. 2005, 96(1):36-46.
50. Ramachandran C., Srinivas S.P. Formation and disassembly of adherens and tight junctions in the corneal endothelium: regulation by actomyosin contraction. Investig. Ophthalmol. Vis. Sci. 2010, 51(4):2139-2148.
51. Rayner S.A., King W.J., Comer R.M., Isaacs J.D., Hale G., George A.J., Larkin D.F. Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation. Clin. Exp. Immunol. 2000, 122(1):109-116.
52. Satpathy M., Gallagher P., Lizotte-Waniewski M., Srinivas S.P. Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells. Exp. Eye Res. 2004, 79(4):477-486.
53. Schindler J.F., Monahan J.B., Smith W.G. p38 pathway kinases as anti-inflammatory drug targets. J.Dent. Res. 2007, 86(9):800-811.
54. Shaw S.K., Perkins B.N., Lim Y.C., Liu Y., Nusrat A., Schnell F.J., Parkos C.A., Luscinskas F.W. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma does not reduce leukocyte transmigration under flow. Am. J. Pathol. 2001, 159(6):2281-2291.
55. Shivanna M., Jalimarada S.S., Srinivas S.P. Lovastatin inhibits the thrombin-induced loss of barrier integrity in bovine corneal endothelium. J.Ocul. Pharmacol. Ther. 2010, 26(1):1-10.
56. Shivanna M., Rajashekhar G., Srinivas S.P. Barrier dysfunction of the corneal endothelium in response to TNF-alpha: role of p38 MAP kinase. Investig. Ophthalmol. Vis. Sci. 2010, 51(3):1575-1582.
57. Shivanna M., Srinivas S.P. Microtubule stabilization opposes the (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium. Exp. Eye Res. 2009, 89(6):950-959.
58. Song H., Ki S.H., Kim S.G., Moon A. Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 2006, 66(21):10487-10496.
59. Srinivas S.P. Dynamic regulation of barrier integrity of the corneal endothelium. Optom. Vis. Sci. 2010, 87(4):E239-E254.
60. Srinivas S.P. Cell signaling in regulation of the barrier integrity of the corneal endothelium. Exp. Eye Res. 2012, 95(1):8-15.
61. Srinivas S.P., Satpathy M., Gallagher P., Lariviere E., Van Driessche W. Adenosine induces dephosphorylation of myosin II regulatory light chain in cultured bovine corneal endothelial cells. Exp. Eye Res. 2004, 79(4):543-551.
62. Turner J.R. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am. J. Pathol. 2006, 169(6):1901-1909.
63. Underwood D.C., Osborn R.R., Bochnowicz S., Webb E.F., Rieman D.J., Lee J.C., Romanic A.M., Adams J.L., Hay D.W., Griswold D.E. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279(5):L895-L902.
64. Valentincic N.V., de Groot-Mijnes J.D., Kraut A., Korosec P., Hawlina M., Rothova A. Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol. Vis. 2011, 17:2003-2010.
65. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92(8):827-839.
66. Walsh S.V., Hopkins A.M., Nusrat A. Modulation of tight junction structure and function by cytokines. Adv. Drug Deliv. Rev. 2000, 41(3):303-313.
67. Wehrle-Haller B. Assembly and disassembly of cell matrix adhesions. Curr. Opin. Cell Biol. 2012, 24(5):569-581.
68. Wigham C.G., Turner H.C., Swan J., Hodson S.A. Modulation of corneal endothelial hydration control mechanisms by Rolipram. Pflug. Arch. 2000, 440(6):866-870.
69. Ye D., Ma I., Ma T.Y. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290(3):G496-G504.
70. Yin F., Watsky M.A. LPA and S1P increase corneal epithelial and endothelial cell transcellular resistance. Investig. Ophthalmol. Vis. Sci. 2005, 46(6):1927-1933.
71. Zhang F.Y., Chen X.C., Ren H.M., Bao W.M. Effects of ischemic preconditioning on blood-brain barrier permeability and MMP-9 expression of ischemic brain. Neurol. Res. 2006, 28(1):21-24.
72. Zhang J., Shen B., Lin A. Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacol. Sci. 2007, 28(6):286-295.